Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rj Kolb

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|March 14, 2013
Update on models of pulmonary fibrosis therapy for preclinical drug researchSabina Antonela Antoniu, Martin Rj Kolb
Current Opinion in Pulmonary Medicine|July 7, 2021
The justification for the progressive fibrotic phenotypeMartin Rj Kolb, Kevin R Flaherty
Expert Review of Respiratory Medicine|October 1, 2019
Treatment of idiopathic pulmonary fibrosis with Nintedanib: an updateAmornpun Wongkarnjana, Toyoshi Yanagihara, Martin Rj Kolb
Thorax|April 16, 2021
Fibrotic extracellular matrix induces release of extracellular vesicles with pro-fibrotic miRNA from fibrocytesSeidai Sato, Sy Giin Chong, Chandak Upagupta, et al.
Biochemical and Biophysical Research Communications|March 23, 2023
Intrinsic BMP inhibitor Gremlin regulates alveolar epithelial type II cell proliferation and differentiationToyoshi Yanagihara, Quan Zhou, Kazuya Tsubouchi, et al.
Thorax|February 11, 2022
Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysisTyler Pitre, Jasmine Mah, Wryan Helmeczi, et al.
Thorax|May 12, 2019
The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosisMeritxell Tort Tarrés, Franziska Aschenbrenner, Regina Maus, et al.
The Journal of Pathology|May 3, 2016
GRP78 and CHOP modulate macrophage apoptosis and the development of bleomycin-induced pulmonary fibrosisEhab A Ayaub, Philipp S Kolb, Zahraa Mohammed-Ali, et al.
Thorax|October 7, 2020
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung diseaseAmy Po Yu Tsai, Seo Am Hur, Alyson Wong, et al.
Immunology and Cell Biology|March 2, 2023
Myeloid-specific deletion of activating transcription factor 6 alpha increases CD11b<sup>+</sup> macrophage subpopulations and aggravates lung fibrosisOlivia Mekhael, Spencer D Revill, Aaron I Hayat, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|March 14, 2013
Update on models of pulmonary fibrosis therapy for preclinical drug researchSabina Antonela Antoniu, Martin Rj Kolb
Current Opinion in Pulmonary Medicine|July 7, 2021
The justification for the progressive fibrotic phenotypeMartin Rj Kolb, Kevin R Flaherty
Expert Review of Respiratory Medicine|October 1, 2019
Treatment of idiopathic pulmonary fibrosis with Nintedanib: an updateAmornpun Wongkarnjana, Toyoshi Yanagihara, Martin Rj Kolb
Thorax|April 16, 2021
Fibrotic extracellular matrix induces release of extracellular vesicles with pro-fibrotic miRNA from fibrocytesSeidai Sato, Sy Giin Chong, Chandak Upagupta, et al.
Biochemical and Biophysical Research Communications|March 23, 2023
Intrinsic BMP inhibitor Gremlin regulates alveolar epithelial type II cell proliferation and differentiationToyoshi Yanagihara, Quan Zhou, Kazuya Tsubouchi, et al.
Thorax|February 11, 2022
Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysisTyler Pitre, Jasmine Mah, Wryan Helmeczi, et al.
Thorax|May 12, 2019
The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosisMeritxell Tort Tarrés, Franziska Aschenbrenner, Regina Maus, et al.
The Journal of Pathology|May 3, 2016
GRP78 and CHOP modulate macrophage apoptosis and the development of bleomycin-induced pulmonary fibrosisEhab A Ayaub, Philipp S Kolb, Zahraa Mohammed-Ali, et al.
Thorax|October 7, 2020
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung diseaseAmy Po Yu Tsai, Seo Am Hur, Alyson Wong, et al.
Immunology and Cell Biology|March 2, 2023
Myeloid-specific deletion of activating transcription factor 6 alpha increases CD11b<sup>+</sup> macrophage subpopulations and aggravates lung fibrosisOlivia Mekhael, Spencer D Revill, Aaron I Hayat, et al.
Pageof 1